What is Lifebloom?
Lifebloom operates as a specialized nutraceutical manufacturing and packaging entity, providing a streamlined ecosystem for supplement brands. By offering a vertically integrated suite of services—ranging from bespoke formulation and graphic design to complex vendor coordination—the company effectively lowers the barrier to entry for emerging health and wellness brands. Their market position is defined by a commitment to operational efficiency, allowing clients to outsource the technical rigors of production while maintaining focus on brand equity and market expansion. The firm's ability to manage both in-house and customized formulations positions it as a critical partner in the rapidly scaling global supplement market.
How much funding has Lifebloom raised?
Lifebloom has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in Lifebloom
PPP
Public-Private Partnership
What's next for Lifebloom?
With this late-stage capital, Lifebloom is poised to transition into a phase of aggressive capacity expansion and technological integration. The strategic roadmap likely involves scaling its manufacturing throughput to meet rising consumer demand for high-quality, transparently sourced supplements. Furthermore, the company is expected to leverage this investment to enhance its packaging automation and supply chain resilience, ensuring that it remains a preferred partner for brands seeking to navigate the complexities of the nutraceutical landscape. As the industry shifts toward more personalized health solutions, Lifebloom's focus on customized formulation services will be instrumental in maintaining its competitive advantage and driving long-term shareholder value.
See full Lifebloom company page
